Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group

The Asia Pacific Malaria Elimination Network (APMEN) is a collaboration of 18 country partners committed to eliminating malaria from within their borders. Over the past 5 years, APMEN has helped to build the knowledge, tools and in-country technical expertise required to attain this goal. At its inaugural meeting in Brisbane in 2009, Plasmodium vivax infections were identified across the region as a common threat to this ambitious programme; the APMEN Vivax Working Group was established to tackle specifically this issue. The Working Group developed a four-stage strategy to identify knowledge gaps, build regional consensus on shared priorities, generate evidence and change practice to optimize malaria elimination activities. This case study describes the issues faced and the solutions found in developing this robust strategic partnership between national programmes and research partners within the Working Group. The success of the approach adopted by the group may facilitate similar applications in other regions seeking to deploy evidence-based policy and practice.

[1]  R. Price,et al.  Artemisinin combination therapy for vivax malaria. , 2010, The Lancet. Infectious diseases.

[2]  J. T. Williams,et al.  Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. , 2000, Molecular biology and evolution.

[3]  Timothy William,et al.  Plasmodium vivax Population Structure and Transmission Dynamics in Sabah Malaysia , 2013, PloS one.

[4]  M. U. Ferreira,et al.  Tracking malaria parasites in the eradication era. , 2014, Trends in parasitology.

[5]  Pardis C. Sabeti,et al.  Genetic Surveillance Detects Both Clonal and Epidemic Transmission of Malaria following Enhanced Intervention in Senegal , 2013, PloS one.

[6]  R. Price,et al.  Trends in malaria research in 11 Asian Pacific countries: an analysis of peer-reviewed publications over two decades , 2011, Malaria Journal.

[7]  C. Moyes,et al.  Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report , 2013, Malaria Journal.

[8]  R. Snow,et al.  Using evidence to change antimalarial drug policy in Kenya , 2000, Tropical medicine & international health : TM & IH.

[9]  J. Baird.  Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria , 2013, Clinical Microbiology Reviews.

[10]  张静,et al.  Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening , 2015 .

[11]  R. Price,et al.  Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax. , 2012, Trends in parasitology.

[12]  G. Shanks.  Control and elimination of Plasmodium vivax. , 2012, Advances in parasitology.

[13]  Samuel A. Assefa,et al.  A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains , 2014, Nature Communications.

[14]  R. Price,et al.  Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis , 2014, The Lancet. Infectious diseases.

[15]  David L. Smith,et al.  A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010 , 2012, PLoS neglected tropical diseases.

[16]  J. Alves,et al.  Using mitochondrial genome sequences to track the origin of imported Plasmodium vivax infections diagnosed in the United States. , 2014, The American journal of tropical medicine and hygiene.

[17]  S. Rogerson,et al.  Plasmodium vivax infection during pregnancy: an important problem in need of new solutions. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Y. Takwoingi,et al.  Rapid diagnostic tests for diagnosing uncomplicated non‐falciparum or Plasmodium vivax malaria in endemic countries , 2014, The Cochrane database of systematic reviews.

[19]  J. Kaplan,et al.  International Committee for Standardization in Haematology: Recommended Screening Test for Glucose‐6‐Phosphate Dehydrogenase (G‐6‐PD) Deficiency , 1979, British journal of haematology.

[20]  J. Baird,et al.  Performance of the CareStart™ G6PD Deficiency Screening Test, a Point-of-Care Diagnostic for Primaquine Therapy Screening , 2011, PloS one.

[21]  Teun Bousema,et al.  Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination , 2011, Clinical Microbiology Reviews.

[22]  The Asia Pacific Malaria Elimination Network (APMEN): Supporting the common goal of a malaria-free Asia Pacific , 2014 .

[23]  S. Hay,et al.  Spatial distribution of G6PD deficiency variants across malaria-endemic regions , 2013, Malaria Journal.

[24]  R. Price,et al.  Contrasting Transmission Dynamics of Co-endemic Plasmodium vivax and P. falciparum: Implications for Malaria Control and Elimination , 2015, PLoS neglected tropical diseases.

[25]  R. Price,et al.  Diagnosis and treatment of Plasmodium vivax malaria. , 2012, Advances in parasitology.

[26]  Qin Cheng,et al.  Systematic Review of Sub-microscopic P. vivax Infections: Prevalence and Determining Factors , 2015, PLoS neglected tropical diseases.

[27]  David L. Smith,et al.  Malaria resurgence: a systematic review and assessment of its causes , 2012, Malaria Journal.

[28]  R. Price,et al.  Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  M. Kahn,et al.  Comparison of Quantitative and Qualitative Tests for Glucose-6-Phosphate Dehydrogenase Deficiency , 2014, The American journal of tropical medicine and hygiene.

[30]  P. Olliaro,et al.  Averting a malaria disaster , 1999, The Lancet.

[31]  Q. Cheng,et al.  Population genetics of Plasmodium falciparum and Plasmodium vivax and asymptomatic malaria in Temotu Province, Solomon Islands , 2013, Malaria Journal.

[32]  Nicholas P. J. Day,et al.  High-Throughput Ultrasensitive Molecular Techniques for Quantifying Low-Density Malaria Parasitemias , 2014, Journal of Clinical Microbiology.

[33]  S. Hay,et al.  The Malaria Atlas Project: Developing Global Maps of Malaria Risk , 2006, PLoS medicine.

[34]  M. Bahlo,et al.  Plasmodium vivax Populations Are More Genetically Diverse and Less Structured than Sympatric Plasmodium falciparum Populations , 2015, PLoS neglected tropical diseases.

[35]  R. Price,et al.  Genetic diversity and population structure of Plasmodium vivax in Central China , 2014, Malaria Journal.

[36]  R. Price,et al.  Vivax malaria: a major cause of morbidity in early infancy. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  Anand P. Patil,et al.  G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map , 2012, PLoS medicine.

[38]  Surveillance..  A Research Agenda for Malaria Eradication: Monitoring, Evaluation, and Surveillance , 2011, PLoS medicine.

[39]  Q. Cheng,et al.  G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests , 2013, Malaria Journal.

[40]  David L. Smith,et al.  Geographical variation in Plasmodium vivax relapse , 2014, Malaria Journal.

[41]  M. Gatton,et al.  Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. , 2007, The Journal of infectious diseases.

[42]  Q. Cheng,et al.  Comparison of Rapid Diagnostic Tests for the Detection of Plasmodium vivax Malaria in South Korea , 2013, PloS one.

[43]  Jung-Yeon Kim,et al.  First Evaluation of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Vivax Malaria Endemic Regions in the Republic of Korea , 2014, PloS one.

[44]  F. Nosten,et al.  Suitability of Capillary Blood for Quantitative Assessment of G6PD Activity and Performances of G6PD Point-of-Care Tests , 2015, The American journal of tropical medicine and hygiene.

[45]  K. Kain,et al.  Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections. , 1996, The Journal of infectious diseases.

[46]  Anand P. Patil,et al.  Plasmodium vivax Malaria Endemicity in Indonesia in 2010 , 2012, PloS one.

[47]  M. Whittaker,et al.  Malaria elimination in Asia–Pacific: an under-told story , 2010, The Lancet.

[48]  Juliana M. Sá,et al.  Higher microsatellite diversity in Plasmodium vivax than in sympatric Plasmodium falciparum populations in Pursat, Western Cambodia. , 2013, Experimental parasitology.

[49]  J. Carlton,et al.  Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. , 2007, The Journal of infectious diseases.

[50]  the IndiSeas Working Group.  Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group , 2015, Malaria Journal.

[51]  R. Price,et al.  Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum , 2008, Malaria Journal.

[52]  R. Price,et al.  Primaquine radical cure of Plasmodium vivax: a critical review of the literature , 2012, Malaria Journal.

[53]  A. Barry,et al.  Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination , 2012, Malaria Journal.

[54]  R. Price,et al.  New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance , 2009, Current opinion in infectious diseases.

[55]  Baird Jk.  Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria , 2013 .

[56]  Hsiao-Han Chang,et al.  Clonal outbreak of Plasmodium falciparum infection in eastern Panama. , 2014, The Journal of infectious diseases.

[57]  Q. Gao,et al.  Adaptation of a visualized loop-mediated isothermal amplification technique for field detection of Plasmodium vivax infection , 2011, Parasites & Vectors.

[58]  R. Price,et al.  Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia , 2014, BMC Medicine.

[59]  J. Jacobs,et al.  Malaria rapid diagnostic tests in endemic settings. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.